These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27815067)

  • 61. CT appearances of HIV-related lipodystrophy syndrome.
    Gellett LR; Haddon L; Maskell GF
    Br J Radiol; 2001 Apr; 74(880):382-3. PubMed ID: 11387159
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [No improvement of lipodystrophy syndrome in an HIV-infected patient].
    Lanzafame M; Faggian F; Lattuada E; Antolini D; Concia E
    Recenti Prog Med; 2004 Jun; 95(6):312-3. PubMed ID: 15248414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).
    Gazzard B;
    HIV Med; 2005 Jul; 6 Suppl 2():1-61. PubMed ID: 16011536
    [No Abstract]   [Full Text] [Related]  

  • 64. Switch therapy studies.
    Mallon PW
    J HIV Ther; 2001 May; 6(2):45-8. PubMed ID: 11505945
    [No Abstract]   [Full Text] [Related]  

  • 65. Complications of long-term antiretroviral therapy in HIV-infected children.
    Prendergast AJ
    Arch Dis Child; 2013 Apr; 98(4):245-6. PubMed ID: 23413313
    [No Abstract]   [Full Text] [Related]  

  • 66. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
    McComsey G
    AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment options for lipodystrophy in HIV-positive patients.
    Behrens GM
    Expert Opin Pharmacother; 2008 Jan; 9(1):39-52. PubMed ID: 18076337
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1-infected patients.
    Zhou HY; Zheng YH; He Y; Chen Z; Liu M; Yin W; Liu C
    Intervirology; 2010; 53(4):240-6. PubMed ID: 20357493
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disorders of body fat distribution in HIV-1-infected patients.
    Moreno S; Miralles C; Negredo E; Domingo P; Estrada V; Gutiérrez F; Lozano F; Martínez E
    AIDS Rev; 2009; 11(3):126-34. PubMed ID: 19654854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changing patterns of morbidity and mortality in HIV disease.
    Calabrese LH
    Cleve Clin J Med; 2001 Feb; 68(2):105, 109-10, 112. PubMed ID: 11220453
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV and insulin resistance in context.
    Kotler DP
    AIDS Read; 2005 May; 15(5):220. PubMed ID: 15900630
    [No Abstract]   [Full Text] [Related]  

  • 72. [Lipodystrophy syndrome. Therapeutic progress is still pending].
    Weber K; Heiken H; Stoll M; Schmidt RE; Behrens G
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():28-32. PubMed ID: 15011581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatitis C virus in patients with HIV infection and lipodystrophy.
    Rodriguez-Guardado A; Maradona JA; Asensi V; Cartón JA; Casado L
    J Acquir Immune Defic Syndr; 2003 Mar; 32(3):348-9. PubMed ID: 12626899
    [No Abstract]   [Full Text] [Related]  

  • 74. [Metabolic changes in HIV infected patient].
    Castelo Filho A; Abrão P
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):5-7. PubMed ID: 17435849
    [No Abstract]   [Full Text] [Related]  

  • 75. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
    Sattler FR
    Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.
    van Griensven J; De Naeyer L; Mushi T; Ubarijoro S; Gashumba D; Gazille C; Zachariah R
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):793-8. PubMed ID: 17467756
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Stigmatization, metabolic trouble, drug resistance: current challenges in HIV therapy].
    Mauss S; Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):28. PubMed ID: 19769068
    [No Abstract]   [Full Text] [Related]  

  • 79. Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome.
    Guzmán-Fulgencio M; Micheloud D; Lorente R; Bellón JM; Gomez MI; Gurbindo MD; León JA; Muñoz-Fernández MÁ; Resino S
    J Infect; 2011 Mar; 62(3):240-3. PubMed ID: 21256862
    [No Abstract]   [Full Text] [Related]  

  • 80. Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones.
    Manfredi R; Calza L; Chiodo F
    J Acquir Immune Defic Syndr; 2004 Jan; 35(1):99-102. PubMed ID: 14707802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.